Qube Research & Technologies LTD Compass Pathways PLC Transaction History

Qube Research & Technologies LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	N/A	19,280 New	19,280 $164,000
Q4 2023 Feb 13, 2024	BUY	N/A	19,493 New	19,493 $166,000
Q2 2022 Aug 15, 2022	SELL	$6.76 - $14.18 $145,623 - $305,465	-21,542 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$11.13 - $23.04 $92,846 - $192,199	-8,342 Reduced 27.91%	21,542 $278,000
Q4 2021 Feb 01, 2022	BUY	$21.81 - $48.96 $651,770 - $1.46 Million	29,884 New	29,884 $660,000
Q3 2021 Nov 12, 2021	SELL	$29.03 - $38.62 $191,220 - $254,389	-6,587 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$32.29 - $39.68 $219,313 - $269,506	-6,792 Reduced 50.77%	6,587 $251,000
Q1 2021 May 14, 2021	BUY	$34.75 - $57.5 $55,912 - $92,517	1,609 Added 13.67%	13,379 $493,000
Q4 2020 Feb 16, 2021	SELL	$32.0 - $59.2 $31,424 - $58,134	-982 Reduced 7.7%	11,770 $561,000
Q3 2020 Nov 12, 2020	BUY	$28.83 - $43.17 $367,640 - $550,503	12,752 New	12,752 $445,000

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.